Technology Offerings

Active Agent Boosts Lung Regeneration for Chronic Diseases

Medicamentous regeneration of forms of lung damage as a result of chronic lung diseases such as COPD, pulmonary fibrosis, asthma etc. is possible for the first time thanks to the new active agent.<br>

The novel active agent may remove the necessity of having to undergo a risky lung transplantation and could cure the disease, making it of interest to a broad patient population.

Further Information: PDF

TransMIT Gesellschaft für Technologietransfer mbH
Phone: +49 (0)641/943 64-12

Contact
Dr. Peter Stumpf

Comments (0)

Write a comment